Abstract | AIMS/HYPOTHESIS: Animal and human studies have implied that enterovirus infections may modulate the risk of islet autoimmunity and type 1 diabetes. We set out to assess whether serial administration of live oral poliovirus vaccine (OPV) in early life can influence the initiation of islet autoimmunity in a cohort of genetically predisposed children. METHODS: RESULTS: Administration of OPV increased enterovirus detected in stool samples from 11.3% to 38.9% (p < 0.001) during the first year of life. During the follow-up (median 11.0 years), at least one autoantibody was detected in 17.2% of children vaccinated with OPV and 19.1% with IPV (p = 0.723). At least two autoantibodies were observed in 3.1% and 6.8% of children, respectively (p = 0.384). CONCLUSIONS/INTERPRETATION: Replication of attenuated poliovirus strains in gut mucosa is not associated with an increased risk of islet autoimmunity. TRIAL REGISTRATION: ClinicalTrials.gov : NCT02961595.
|
Authors | Hanna Viskari, Sami Oikarinen, Sanna Hoppu, Tytti Vuorinen, Heini Huhtala, Jorma Toppari, Riitta Veijola, Jorma Ilonen, Mikael Knip, Heikki Hyöty |
Journal | Diabetologia
(Diabetologia)
Vol. 61
Issue 1
Pg. 203-209
(01 2018)
ISSN: 1432-0428 [Electronic] Germany |
PMID | 28866779
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Viral
- Autoantibodies
- Poliovirus Vaccine, Oral
|
Topics |
- Antibodies, Viral
(immunology)
- Autoantibodies
(immunology)
- Autoimmunity
(genetics, physiology)
- Diabetes Mellitus, Type 1
(genetics, prevention & control, virology)
- Enterovirus
(genetics)
- Genetic Predisposition to Disease
(genetics)
- Humans
- Poliovirus Vaccine, Oral
(therapeutic use)
- Reverse Transcriptase Polymerase Chain Reaction
|